REGENERON PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 506682000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2012-09-30) |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:06.709867+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a3b07636-aa39-4cea-ba9b-c4394b4e3e58
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001532176-12-000004Retrieved: 2026-08-19T08:39:06.709867+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/accounts-receivable/2012-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a3b07636-aa39-4cea-ba9b-c4394b4e3e58
History
- no predecessors — first report